Gilead announced that the FDA has approved Sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis C infection as part of a combination antiviral treatment regimen.
Teva announced the launch of Imiquimod Cream, the generic version of Medicis' Aldara Cream.
The FDA has approved a new indication for Xiaflex (collagenase clostridium histolyticum; Auxilium) for the treatment of Peyronie's disease, a curvature deformity of the penis due to the presence of a plaque.
Shire announced top-line results from OPUS-2, a Phase 3 efficacy and safety study of 5.0% lifitegrast ophthalmic solution for dry eyes.
Preliminary results from an NIH-supported clinical trial showed that men with hormone-sensitive metastatic prostate cancer who received docetaxel at the start of standard hormone therapy lived longer than patients who received hormone therapy alone.